Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSkeletal Plasmacytoma: Progression of disease and impact of local treatment; an analysis of SEER database
Journal of Hematology & Oncology, 09/28/09
Jawad MU et al. – Plasmacytoma consists of two cohorts of patients with different overall survival; those patients that do not progress to systemic disease and those that develop myeloma. Age > 60 years is associated with disease progression. Identifying patients with systemic disease early in the treatment will permit aggressive and novel treatment strategies to be implemented.
Related Articles
Plasmacytoma Of Larynx—A Case Report
Journal of Voice, 11/19/09
Relevance Score: 88%
Synchronous presentation of extramedullary plasmacytoma in the nasopharynx and the larynx
ENT Journal, 11/20/09
Relevance Score: 80%
Intracranial plasmacytoma as an initial presentation of multiple myeloma
Central European Journal of Medicine, 11/10/09
Relevance Score: 80%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
Oncogene, 12/16/09
Mechanisms of breast cancer bone metastasis
Cancer Letters, 12/16/09
Noninvasive Prediction of Fracture Risk in Patients with Metastatic Cancer to the Spine
Clinical Cancer Research, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor